Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Julie A. Lofgren
Observed names:
J A Lofgren,
Julie A Lofgren,
Julie Lofgren
Institution:
Amgen (United States)
Observed institutions:
Amgen (United States),
Genentech
OpenAlex ID:
A5113524890
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
2002
·
David B Agus
, Robert W Akita
, et al.
·
Cancer Cell
·
950
PDF
Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing
2017
·
Sandra L. Ross
, Marika Sherman
, et al.
·
PLoS ONE
·
137
PDF
Binding Interaction of the Heregulinβ egf Domain with ErbB3 and ErbB4 Receptors Assessed by Alanine Scanning Mutagenesis
1998
·
Jennifer T. Jones
, Marcus D. Ballinger
, et al.
·
Journal of Biological Chemistry
·
65
MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways
2014
·
Anne Y. Saiki
, Sean Caenepeel
, et al.
·
Oncotarget
·
55
PDF
Selection of Heregulin Variants Having Higher Affinity for the ErbB3 Receptor by Monovalent Phage Display
1998
·
Marcus D. Ballinger
, Jennifer T. Jones
, et al.
·
Journal of Biological Chemistry
·
50
Kinetic Mechanism of AKT/PKB Enzyme Family
2006
·
Xiaoling Zhang
, Shiwen Zhang
, et al.
·
Journal of Biological Chemistry
·
43
PDF
A potential role for activated HER-2 in prostate cancer.
2000
·
D B Agus
, R W Akita
, et al.
·
PubMed
·
41
Heregulins and the ErbB-2/3/4 receptors in gliomas
1997
·
Manfred Westphal
, Leonie Meima
, et al.
·
Journal of Neuro-Oncology
·
36
Analysis of Heregulin-Induced ErbB2 Phosphorylation with a High-Throughput Kinase Receptor Activation Enzyme-Linked Immunosorbant Assay
1996
·
Michael D. Sadick
, Mark X. Sliwkowski
, et al.
·
Analytical Biochemistry
·
26
2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics
2010
·
Qingping Zeng
, Matthew P. Bourbeau
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
25
Azole-based inhibitors of AKT/PKB for the treatment of cancer
2010
·
Qingping Zeng
, John G. Allen
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
19
Design and synthesis of novel amide AKT1 inhibitors with selectivity over CDK2
2011
·
Kate S. Ashton
, David J. St. Jean
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
9
Abstract LB-232: BiTE antibody constructs can mediate bystander tumor cell killing
2015
·
Sandra L. Ross
, Marika Mulen
, et al.
·
Cancer Research
Show more works
View as search
Works count:
13
Citation count:
1,456
H-index:
11
I10-index:
11
Year
Topic
Type